In the News: First-Ever AI Parameters Ruling; New Pharma Strategy; and Market Access Restrictions Eased

Beijing IP Court issues first ruling on protecting AI model parameters; Chinese pharma companies are using “NewCo” strategy to expand overseas; and China reduces entry restrictions for select industries.

By CLP staff

In the News: First-Ever AI Parameters Ruling; New Pharma Strategy; and Market Access Restrictions Eased

Douyin Wins AI Model Unfair Competition Case

On March 31, 2025, the Beijing Intellectual Property Court issued a landmark judgment which, for the first time in China, held that the structure and parameters of AI models “constitute competitive interests protected under the Anti-Unfair Competition Law.”

Douyin, China’s version of TikTok, has a “comic transformation effect” feature on its app on Android.

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)